Despite the Biden administration's numerous initiatives to crack down on the high cost of drugs, several big drugmakers will hike prices this month, with Pfizer announcing over a quarter of the increases.
After the Federal Trade Commission sent warning letters to 10 drugmakers over 100 "improper" patents, 3 chose to delist their patents from the FDA's registry, potentially accelerating the approval of generic versions.
One of the nation's largest health insurance providers was using the same AI tool, nH Predict – with an alleged 90% error rate that overrides medical judgment – that UnitedHealthcare was sued for in November.
Osterhaus Pharmacy in Iowa filed a class action lawsuit against UnitedHealth's pharmacy benefit manager Optum Rx, alleging it forces pharmacies to agree to retroactive fees that can cause pharmacies to dispense drugs at a loss.
The popular AI tool's answers to most drug-related questions were incomplete or wrong in a new study, cautioning health care professionals about using ChatGPT as an "authoritative source for medication-related information."
Although 86% are satisfied with their current health and medical benefit offerings, they are inundated with the management of 49 or more narrowly focused, condition-specific point solutions.
The Department of Health and Human Services' health care tech arm finalized a new rule last week that requires AI developers to detail how products are maintained and monitored -- and goes into effect at the end of 2024.